ASHLEE PAKNIS: Open Payments
NPI 1144877747 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,228 in 175 payments from 21 companies in 2025. Trend: 2023 $1,852 · 2024 $1,905 · 2025 $3,228
Food & beverage: $3,129Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $530 |
| GENZYME CORPORATION | 14 | $518 |
| Arcutis Biotherapeutics, Inc. | 43 | $399 |
| Regeneron Healthcare Solutions, Inc. | 13 | $284 |
| ABBVIE INC. | 21 | $249 |
| Janssen Biotech, Inc. | 7 | $158 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 9 | $152 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $150 |
| Incyte Corporation | 6 | $129 |
| Novartis Pharmaceuticals Corporation | 4 | $123 |
Products named: DUPIXENT, Bimzelx, Zoryve, TREMFYA, Cabtreo, SKYRIZI, OPZELURA, RINVOQ.
Industry payments across NJ — which companies pay providers there.
